604 related articles for article (PubMed ID: 32088543)
1. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
[TBL] [Abstract][Full Text] [Related]
2. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2021 Dec; 157():106789. PubMed ID: 34333293
[TBL] [Abstract][Full Text] [Related]
4. Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2021 Mar; 148():106375. PubMed ID: 33482440
[TBL] [Abstract][Full Text] [Related]
5. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2019 Aug; 129():343-353. PubMed ID: 31150976
[TBL] [Abstract][Full Text] [Related]
6. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
[TBL] [Abstract][Full Text] [Related]
7. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
8. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
[TBL] [Abstract][Full Text] [Related]
9. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.
Cardenas A; Gold DR; Hauser R; Kleinman KP; Hivert MF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
Environ Health Perspect; 2017 Oct; 125(10):107001. PubMed ID: 28974480
[TBL] [Abstract][Full Text] [Related]
10. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
11. Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study.
Osorio-Yáñez C; Sanchez-Guerra M; Cardenas A; Lin PD; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2021 Jun; 151():106446. PubMed ID: 33631604
[TBL] [Abstract][Full Text] [Related]
12. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
Kang H; Kim SH
Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
[TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
14. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
15. Prenatal and Childhood Per- and Polyfluoroalkyl Substance (PFAS) Exposures and Blood Pressure Trajectories From Birth to Late Adolescence in a Prospective US Prebirth Cohort.
Zhang M; Aris IM; Lin PD; Rifas-Shiman SL; Brady TM; James-Todd T; Oken E; Hivert MF
J Am Heart Assoc; 2023 Sep; 12(17):e030760. PubMed ID: 37642023
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.
Mitro SD; Sagiv SK; Fleisch AF; Jaacks LM; Williams PL; Rifas-Shiman SL; Calafat AM; Hivert MF; Oken E; James-Todd TM
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3415-26. PubMed ID: 32620010
[TBL] [Abstract][Full Text] [Related]
17. Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults.
Pitter G; Zare Jeddi M; Barbieri G; Gion M; Fabricio ASC; Daprà F; Russo F; Fletcher T; Canova C
Environ Health; 2020 Sep; 19(1):102. PubMed ID: 32958007
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
19. Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort.
Birukov A; Andersen LB; Andersen MS; Nielsen JH; Nielsen F; Kyhl HB; Jørgensen JS; Grandjean P; Dechend R; Jensen TK
Environ Int; 2021 Jun; 151():106442. PubMed ID: 33610053
[TBL] [Abstract][Full Text] [Related]
20. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
